Title: Liansheng Li, et al. Inhibitors of kras g12c. WO 2015054572 A1.
Title: Janes MR, et al. Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor. Cell. 2018 Jan 25;172(3):578-589.e17.
1698055-85-4
2436544-27-1
615253-61-7 | SP187 | AA01EOOL | MFCD28502268
870554-67-9 | 5Z-[(5-bromo-2-methoxyphenyl)methylene]-3-[(4-methylphenyl)methyl]-2,4-thiazolidinedione | AA01EOWZ | MFCD28334212
154086-90-5 | 9Z-octadecenoicacid,1-(7-carboxyheptyl)decylester | AA01EP70
91032-37-0 | 34-O-[2-(acetylamino)-2-deoxy-β-D-glucopyranosyl]-22,31-dichloro-7-demethyl-64-O-demethyl-19-deoxy-56-O-[2-deoxy-2-[(8-methyl-1-oxodecyl)amino]-β-D-glucopyranosyl]-42-O-α-D-mannopyranosyl-ristomycinAaglycone | AA01EPFO | MFCD01750326
17187-72-3 | 7-(dihydrogenphosphate),sedoheptulose,monobariumsalt | AA01EPKV
91700-91-3 | 18,21-didehydro-17-demethoxy-18,21-dideoxo-18,21-dihydroxy-15R-methoxy-geldanamycin | AA01EPRL | MFCD09752707
97040-38-5 | 30-[[2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]amino]-30-oxotriacontylester,9,12-octadecadienoicacid | AA01EQ02
1092804-87-9 | N-(2,6-dimethylphenyl)-4-[2-hydroxy-3-(2-methoxyphenoxy)propyl-1,1,2,3,3-d5]-1-piperazineacetamide | AA01EQ7G
1627716-22-6 | CD161 | AA01EQD5
1197238-08-6 | 1-(1,4-benzodioxane-6-yl)ethylamine | AA01EQVS | MFCD09025438
